Ardisia pusilla
Ardisia pusilla · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Ardisia pusilla is a plant species currently being investigated for its significant potential in anticancer activities. Research focuses on its ability to combat conditions such as breast cancer and gastric cancer by influencing cell migration and cellular senescence. The therapeutic efficacy of the plant is largely attributed to its rich chemical profile, which includes coumarins, flavonoids, lignans, and steroids. These bioactive compounds are typically studied through specialized preparations, most notably the plant extract and the n-butanol fraction. Consequently, this species represents a promising subject in the ongoing search for natural pharmacological agents.
- Synonyms
- Bladhia Villosa · Bladhia Villosa Var. Liukiuensis · 2 more
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Ardisia pusilla is a versatile plant known by a variety of distinct common names across different regions. In many contexts, it is simply referred to as ツルコウジ, though it is also frequently identified as リュウキュウツルコウジ. This name is often transliterated as リュウキュウツルコウジ (ryukyu-tsuru-kouzi) to provide clearer phonetic guidance. In Chinese-speaking areas, the species is recognized by the names 九節龍 and 輪葉紫金牛. Understanding these various linguistic identities is essential for anyone studying the plant's diverse botanical heritage.
Sources: Catalogue of Life (COL)
Synonyms
Ardisia pusilla is a plant species with a complex taxonomic history involving several identified synonyms. It has been formally classified under the name Ardisia pusilla f. liukiuensis in certain botanical contexts. Additionally, the species is linked to the names Ardisia villosa var. liukiuensis and Bladhia villosa. Further records also associate the plant with the synonym Bladhia villosa var. liukiuensis. These various designations highlight the evolving scientific understanding of its botanical relationships.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Ardisia pusilla is a distinctive member of the kingdom Plantae. This species is classified under the class Equisetopsida and belongs to the order Ericales. Within this botanical hierarchy, it is nested in the family Primulaceae. Further refinement of its identity places it specifically within the genus Ardisia. Understanding these relationships provides essential insight into the evolutionary placement of this unique plant.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Ardisia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ardisia pusilla is a plant species primarily distributed throughout the temperate regions of Asia. Its presence is well-documented across various parts of China, including both the South-Central and Southeast territories. The species also extends its reach into Eastern Asia, where it can be found naturally in Japan and Korea. Furthermore, its range encompasses the Nansei-shoto islands, showcasing its adaptability to different island environments. This diverse geographic footprint highlights the plant's significant ecological presence across the Asian continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ardisia pusilla is a compact shrub that grows as a self-supporting plant. This species typically maintains a very modest stature within its natural habitat. Its height generally ranges from a minimum of 0.3 meters to a maximum of 0.4 meters. For many specimens, a height of at least 0.35 meters is commonly observed. Overall, its small scale makes it a subtle yet distinct part of the undergrowth.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Ardisia pusilla belongs to a genus of plants that holds significant promise in the field of pharmaceutical research. While specific studies on this species are ongoing, related members of the genus, such as Ardisia villosa, have demonstrated potent anticancer properties. Research indicates that extracts from these plants can effectively inhibit the proliferation of breast and gastric cancer cell lines. These bioactive compounds work by inducing cell cycle arrest and triggering cellular senescence to prevent tumor growth. Consequently, these botanical findings highlight the potential of the Ardisia genus as a valuable natural source for future cancer therapeutics.
Compounds
Ardisia pusilla is a plant species notable for its diverse and significant phytochemical composition. Detailed analysis reveals that this plant contains a variety of bioactive compounds, including coumarins, flavonoids, and lignans. Furthermore, the presence of steroids within its chemical profile contributes to its complex biological makeup. Research specifically highlights that Ardisia pusilla contains bergenin, with studies indicating a minimum content of 59%. These various constituents underscore the botanical importance and chemical richness of the species.
Conditions
Ardisia pusilla, specifically through its n-butanol fraction, demonstrates significant anticancer potential against both breast and gastric cancer cell lines. In gastric cancer models, the extract effectively treats 3D tumorsphere formation and suppresses cell migration. The plant also treats cellular senescence by inducing the upregulation of tumor suppressor and senescence-related genes. These diverse biological activities suggest that the plant works through multi-targeted mechanisms to inhibit cancer cell proliferation. Together, these properties highlight its ability to combat various hallmarks of malignancy.
Preparations
Ardisia pusilla is prepared as an extract for various phytochemical and biological studies. This plant is also processed to be prepared as an n-butanol fraction to isolate specific bioactive compounds. Such preparation methods allow for the detailed investigation of the plant's chemical profile and therapeutic potential. By utilizing these different forms, researchers can better understand the concentration of secondary metabolites within the species. Consequently, both the crude extract and the n-butanol fraction serve as essential components in evaluating the plant's pharmacological properties.